Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of DAA-I in Healthy Subjects
NCT02666196Phase 1Completed
- Sponsor
- National University Hospital
- Start
- Sep 2015
- Primary completion
- Dec 2015
- Modality
- Peptides, Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of des-aspartate-angiotensin I (4 arms), sponsored by National University Hospital. Primary endpoint: Safety and dose range of DAA-I at 24 hours. Started Sep 2015; status: completed.
02
Drugs
des-aspartate-angiotensin I
Beyond the preview
Go deeper on NCT02666196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02666196.